• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma.

作者信息

Nakashima Kazuhisa, Naito Tateaki, Omori Shota, Yoshikawa Shusuke, Endo Masahiro, Kiyohara Yoshio, Takahashi Toshiaki

机构信息

Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

出版信息

J Thorac Oncol. 2016 Mar;11(3):432-3. doi: 10.1016/j.jtho.2015.10.004. Epub 2015 Dec 24.

DOI:10.1016/j.jtho.2015.10.004
PMID:26723243
Abstract
摘要

相似文献

1
Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma.纳武单抗诱发的转移性黑色素瘤患者机化性肺炎
J Thorac Oncol. 2016 Mar;11(3):432-3. doi: 10.1016/j.jtho.2015.10.004. Epub 2015 Dec 24.
2
Nivolumab-induced organizing pneumonia in a melanoma patient.一名黑色素瘤患者出现的纳武单抗诱导的机化性肺炎。
Jpn J Clin Oncol. 2016 Mar;46(3):270-2. doi: 10.1093/jjco/hyv199. Epub 2016 Jan 12.
3
Severe pneumonitis after nivolumab treatment in a patient with melanoma.一名黑色素瘤患者接受纳武单抗治疗后发生严重肺炎。
Allergol Int. 2016 Oct;65(4):487-489. doi: 10.1016/j.alit.2016.04.009. Epub 2016 May 13.
4
Nivolumab in previously untreated melanoma without BRAF mutation.纳武利尤单抗治疗未经 BRAF 突变检测的初治黑色素瘤。
N Engl J Med. 2015 Jan 22;372(4):320-30. doi: 10.1056/NEJMoa1412082. Epub 2014 Nov 16.
5
Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials.纳武利尤单抗治疗 BRAF V600 突变型和野生型晚期黑色素瘤患者的疗效和安全性：四项临床试验的汇总分析。
JAMA Oncol. 2015 Jul;1(4):433-40. doi: 10.1001/jamaoncol.2015.1184.
6
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.纳武利尤单抗对比化疗用于 CTLA-4 治疗后进展的晚期黑色素瘤患者（CheckMate 037）：一项随机、对照、开放标签、III 期临床试验。
Lancet Oncol. 2015 Apr;16(4):375-84. doi: 10.1016/S1470-2045(15)70076-8. Epub 2015 Mar 18.
7
Addendum: Nivolumab (Opdivo) for metastatic melanoma and metastatic NSCLC.
Med Lett Drugs Ther. 2015 Jun 22;57(1471):94.
8
Nivolumab (Opdivo) for metastatic melanoma and metastatic NSCLC.
Med Lett Drugs Ther. 2015 Jun 8;57(1470):85-7, 94.
9
Nivolumab (Opdivo) plus ipilimumab (Yervoy) for metastatic melanoma.
Med Lett Drugs Ther. 2015 Dec 7;57(1483):168.
10
Nivolumab provides favorable results in patients with advanced melanoma.
Am J Manag Care. 2014 Mar;20(5 Spec No.):E11.

引用本文的文献

1
Fever of unknown origin associated with immune checkpoint inhibitors.与免疫检查点抑制剂相关的不明原因发热。
Front Immunol. 2024 Mar 12;15:1364128. doi: 10.3389/fimmu.2024.1364128. eCollection 2024.
2
Immune checkpoint inhibitors in metastatic melanoma therapy (Review).免疫检查点抑制剂在转移性黑色素瘤治疗中的应用（综述）
Med Int (Lond). 2024 Feb 9;4(2):13. doi: 10.3892/mi.2024.137. eCollection 2024 Mar-Apr.
3
Secondary Organising Pneumonia Caused by Denosumab.地诺单抗引起的继发性机化性肺炎。
Eur J Case Rep Intern Med. 2023 Sep 15;10(10):004043. doi: 10.12890/2023_004043. eCollection 2023.
4
Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis.免疫检查点抑制剂相关肺炎的潜在发病机制及治疗选择的见解
Biomedicines. 2021 Oct 16;9(10):1484. doi: 10.3390/biomedicines9101484.
5
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer.特瑞普利单抗治疗局部晚期非小细胞肺癌患者后肺炎的预后影响。
Invest New Drugs. 2022 Apr;40(2):403-410. doi: 10.1007/s10637-021-01191-6. Epub 2021 Oct 11.
6
Treatment and outcome of a patient with radiation-induced organizing pneumonia in the context of coronavirus disease 2019 (COVID-19).2019冠状病毒病（COVID-19）背景下放射性肺炎患者的治疗与转归
Radiother Oncol. 2021 Jun;159:144-145. doi: 10.1016/j.radonc.2021.03.028. Epub 2021 Mar 29.
7
Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: Focus on Nivolumab.免疫检查点抑制剂相关性肺毒性：聚焦纳武利尤单抗。
South Med J. 2020 Nov;113(11):600-605. doi: 10.14423/SMJ.0000000000001166.
8
Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.抗PD-1治疗所致肺炎的放射学特征的预后意义
Cancer Med. 2020 May;9(9):3070-3077. doi: 10.1002/cam4.2974. Epub 2020 Mar 9.
9
Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long-acting activated memory cells induced by nivolumab against malignant melanoma.肺转移灶的扩增与消退取决于糖皮质激素剂量，这与纳武单抗诱导的针对恶性黑色素瘤的长效活化记忆细胞有关。
Clin Case Rep. 2019 Jul 31;7(9):1709-1713. doi: 10.1002/ccr3.2349. eCollection 2019 Sep.
10
Granuloma-forming interstitial pneumonia induced by nivolumab: a possible immune-related adverse event of the lung.纳武单抗诱导的肉芽肿性间质性肺炎：一种可能的肺部免疫相关不良事件。
Int Cancer Conf J. 2017 Apr 4;6(3):131-134. doi: 10.1007/s13691-017-0291-0. eCollection 2017 Jul.